Skip to main content

Table 4 Association between serological status and social-integration conditions**

From: Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients

Characteristics

HIV

HBV

HCV

TPHA

  

OR

95%CI*

OR

95%CI*

OR

95%CI*

OR

95%CI*

Centre

centre no. 1

1

   

1

   
 

centre no. 2

1.71

(0.37,7.99)

-

-

6.63

(1.26,34.98)

-

-

 

centre no. 3

1.85

(0.54, 6.27)

-

-

2.52

(1.09,5.85)

-

-

 

centre no. 4

1.73

(0.49, 6.07)

-

-

13.23

(2.73,64.17)

-

-

 

centre no. 5

1.44

(0.48, 4.33)

-

-

3.74

(1.54,9.06)

-

-

 

centre no. 6

1.74

(0.44, 6.97)

-

-

6.88

(1.72,27.56)

-

-

 

centre no. 7

1.26

(0.25, 6.39)

-

-

-

-

-

-

 

centre no. 8

0.94

(0.22, 3.99)

-

-

1.93

(0.67,5.62)

-

-

 

centre no. 9

1.53

(0.47, 5.01)

-

-

2.93

(1.25,6.83)

-

-

 

centre no. 10

3.84

(0.89, 16.53)

-

-

1.13

(0.36,3.62)

-

-

 

centre no. 11

-

-

-

-

1.41

(0.44,4.52)

-

-

 

centre no. 12

2.91

(0.64, 13.25)

-

-

11.69

(1.31,104.25)

-

-

 

centre no. 13

1.05

(0.33, 3.41)

-

-

2.06

(0.99, 4.29)

-

-

 

centre no. 14

0.65

(0.06, 6.45)

-

-

2.49

(0.77, 8.08)

-

-

 

centre no. 15

0.61

(0.14, 2.64)

-

-

1.58

(0.65, 3.86)

-

-

 

centre no. 16

0.85

(0.27, 2.65)

-

-

0.77

(0.37, 1.58)

-

-

Age

one year increase

1.01

(0.95, 1.07)

1.01

(0.97, 1.05)

0.99

(0.95, 1.03)

1.00

(0.87, 1.15)

Sex

Female

1

 

1

 

1

 

1

 
 

Male

0.64

(0.37, 1.11)

1.14

(0.70, 1.87)

0.75

(0.44, 1.29)

0.22

(0.07, 0.74)†

Duration of the drug use

one year increase

1.14

(1.08, 1.21)†

1.13

(1.09, 1.18)†

1.19

(1.14,1.24)†

1.14

(1.00, 1.31)†

Education

Primary

1

 

1

 

1

 

1

 
 

Middle

0.68

(0.35, 1.31)

1.18

(0.66, 2.11)

1.83

(0.92, 3.61)

0.91

(0.18, 4.72)

 

Vocational

0.42

(0.16, 1.07)

0.95

(0.44, 2.06)

1.24

(0.56, 2.75)

1.17

(0.16, 8.70)

 

Secondary or higher

0.48

(0.19, 1.20)

0.57

(0.27, 1.22)

1.26

(0.56, 2.83)

0.51

(0.04, 6.44)

Employment

Employed

1

 

1

 

1

 

1

 
 

Unemployed

1.86

(1.13, 3.05)†

1.62

(0.98, 2.67)

1.62

(0.92, 2.85)

3.73

(1.26,11.03)†

 

Other

3.52

(1.63, 7.61)†

0.92

(0.37, 2.24)

0.94

(0.56, 1.58)

1.47

(0.16, 8.70)

Living status

Parents

1

 

1

 

1

 

1

 
 

Partner

1.52

(0.69, 3.38)

1.18

(0.66, 2.11)

0.94

(0.56, 1.58)

0.52

(0.10, 2.61)

 

Alone

1.05

(0.56, 1.96)

0.88

(0.52, 1.48)

1.67

(0.39, 5.66)

-

-

 

Friends

0.58

(0.06, 5.25)

1.59

(0.43, 5.86)

1.48

(0.93, 2.98)

0.86

(0.20, 3.75)

Partner

Steady, non D.U.

1

 

1

 

1

 

1

 
 

Steady and D.U.

1.80

(0.98, 3.32)

1.28

(0.76, 2.17)

1.97

(1.16,3.36)†

0.23

(0.04, 1.21)

 

No partner

1.73

(0.79, 3.80)

1.32

(0.77, 2.26)

1.38

(0.86, 2.23)

0.43

(0.10, 1.92)

  1. **: Logistic regression adjusted by recruitment unit, sex, age and duration of drug use; due to sparseness, the adjustment for recruitment site was omitted for HBV and TPHA; *: 95% Confidence Interval; †: p-value < 0.05.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us